Paul Tudor Jones’s West Pharmaceutical WST Stock Holding History

Paul Tudor Jones’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,500	Closed	-$985K	–	3970
2025 Q2	$985K	Buy	4,500 +3,200	+246%	+$684K	﹤0.01%	2139
2025 Q1	$291K	Buy	1,300 +100	+8%	+$27.6K	﹤0.01%	2608
2024 Q4	$393K	Sell	1,200 -5,500	-82%	-$1.73M	﹤0.01%	2398
2024 Q3	$2.01M	Buy	+6,700	New	+$2.05M	0.01%	1199
2023 Q4	–	Sell	-800	Closed	-$300K	–	2962
2023 Q3	$300K	Sell	800 -800	-50%	-$309K	﹤0.01%	1930
2023 Q2	$612K	Buy	+1,600	New	+$572K	0.01%	1596
2021 Q3	–	Sell	-1,400	Closed	-$504K	–	2847
2021 Q2	$504K	Buy	+1,400	New	+$463K	0.01%	1149

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Paul Tudor Jones's WST Position: Q2 2026 in Review

Paul Tudor Jones reduced its West Pharmaceutical (WST) stake by 64% in Q2 2026, selling an estimated $12.7M and leaving 23,851 shares worth $8.56M. The position accounts for 0.01% of the portfolio, ranked #916.

Paul Tudor Jones first reported a position in WST in Q2 2013 and has held it in 27 quarters since. The position peaked at $20.6M in Q3 2023. 827 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Paul Tudor Jones held 23,851 shares of West Pharmaceutical worth $8.56M as of Q2 2026.
Paul Tudor Jones sold 41,564 West Pharmaceutical shares in Q2 2026, an estimated $12.7M.
West Pharmaceutical made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #916 holding.
Paul Tudor Jones first reported a position in West Pharmaceutical in Q2 2013 and has held it in 27 quarters since.
Paul Tudor Jones's West Pharmaceutical position peaked at $20.6M in Q3 2023.
827 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.